/
Chemical Resistance and Material Compatibility Testing/
ISO 10993-21 Evaluation of Degradation ProductsComplete Guide to ISO 10993-21 Evaluation of Degradation Products Laboratory Testing Service Provided by Eurolab
ISO 10993-21 is a standard for the evaluation of degradation products from medical devices, specifically focusing on the assessment of potential health hazards associated with these products. This standard is part of the ISO 10993 series, which provides guidelines for the biological evaluation of medical devices.
Relevant Standards
Legal and Regulatory Framework
The ISO 10993 series is widely recognized as a standard for the biological evaluation of medical devices. Compliance with these standards is mandatory for medical device manufacturers seeking to market their products globally. Non-compliance can result in product recalls, financial penalties, and damage to reputation.
International and National Standards
Standard Development Organizations
The standards development process is managed by international organizations such as the International Organization for Standardization (ISO), the American Society for Testing and Materials (ASTM), and the European Committee for Standardization (CEN).
Evolution of Standards
Standards are regularly updated to reflect new scientific evidence, advances in technology, and changing regulatory requirements. Manufacturers must stay informed about updates to ensure compliance.
Standard Numbers and Scope
Scope: Provides a framework for the biological evaluation of medical devices.
Scope: Provides guidance on testing for delayed type hypersensitivity.
Standard Compliance Requirements
Compliance with these standards is mandatory for medical device manufacturers seeking to market their products globally. Failure to comply can result in product recalls, financial penalties, and damage to reputation.
Standard-Related Testing Services Provided by Eurolab
Eurolab offers a comprehensive range of testing services related to ISO 10993-21 Evaluation of Degradation Products, including:
Why This Specific Test is Needed and Required
The ISO 10993-21 Evaluation of Degradation Products test is required to assess the potential health hazards associated with medical devices. This includes evaluating the toxicity, genotoxicity, and carcinogenicity of degradation products.
Business and Technical Reasons for Conducting the Test
Consequences of Not Performing This Test
Failure to conduct this test can result in:
Industries and Sectors that Require This Testing
Medical device manufacturers, regulatory authorities, and industry associations require this testing.
Risk Factors and Safety Implications
The risk factors associated with medical devices include:
Quality Assurance and Quality Control Aspects
Eurolab ensures the quality of its services through:
Why This Test Contributes to Product Safety and Reliability
This test contributes to product safety and reliability by:
Competitive Advantages of Having This Testing Performed
Performing this testing provides competitive advantages, including:
Cost-Benefit Analysis of Performing This Test
The cost-benefit analysis of performing this test is positive, as it ensures compliance with regulatory requirements, protects patients from potential health risks, and improves product quality.
Introduction to Testing
Eurolabs testing services for ISO 10993-21 Evaluation of Degradation Products involve the following steps:
1. Sample preparation
2. In vitro cytotoxicity testing
3. Delayed type hypersensitivity testing
4. Material characterization and identification
Test Conditions
The test conditions are as follows:
Methodology
Eurolabs methodology for testing degradation products involves the following steps:
1. Sample preparation
Material sampling and extraction
Preparation of test samples
2. In vitro cytotoxicity testing
Cell culture preparation
Testing of sample extracts
3. Delayed type hypersensitivity testing
Cell culture preparation
Testing of sample extracts
4. Material characterization and identification
Spectroscopy (e.g., FTIR, NMR)
Chromatography (e.g., GC, HPLC)
Quality Control and Assurance
Eurolab ensures the quality of its services through:
Conclusion
In conclusion, Eurolabs comprehensive range of testing services for ISO 10993-21 Evaluation of Degradation Products ensures compliance with regulatory requirements, protects patients from potential health risks, and improves product quality.